Effects of recombinant human erythropoietin in preterm newborns with infectious diseases.


de Vasconcelos P Aguiar IF, Krebs VL, Gualandro SF, Silveira PA, Vaz FA.

Rev Assoc Med Bras. 2007;53(1):90-4. Article in Portuguese. PMID: 17420902



Anemia Treatment and Erythropoietin therapy Guidelines

Protocol based on scientific evidence for the non-transfusional treatment of anemia through the appropriate use of iron and erythropoietin.

Welcome to Bloodless


Blood transfusions are currently one of the most performed medical procedures in the world. However, the medical literature shows a relationship between the use of allogeneic (donated) blood and greater complications, including, greater mortality. Worldwide, there is a deficiency in medical knowledge about transfusion practice.


1. To change the current transfusion practice, through the application of scientifically safe and effective PROTOCOLS for the TREATMENT OF ANEMIA and MANAGEMENT OF BLEEDING without the use of allogeneic blood, based on the scientific evidence of modern medicine.

2. Help blood banks SAVE their main HEMOCOMPONENTS (red blood cells, plasma and platelets)